Olaparib beyond progression compared with platinum chemotherapy after secondary cytoreductive surgery in patients with recurrent ovarian cancer: phase III randomized, open-label MITO 35b study, a project of the MITO-MANGO groups.

Clorinda SchettinoLucia MusacchioMichele BartolettiPaolo ChiodiniLaura ArenareGustavo BaldassarreDaniela CalifanoEttore CapoluongoMaria Paola CostiMaurizio D'IncalciSergio MarchiniMezzanzanica DeliaNicola NormannoStefania ScalaStefano GreggiFrancesco PerroneSandro Pignata

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)

EudraCT 2021-000245-41 NCT05255471.

Keyphrases

phase iii
open label
phase ii
clinical trial
double blind
placebo controlled
phase ii study
minimally invasive
coronary artery bypass
randomized controlled trial
squamous cell carcinoma
acute coronary syndrome
coronary artery disease
radiation therapy
surgical site infection
metastatic renal cell carcinoma